Contract analysis

I. Executive Summary This memorandum has been prepared by Calderwood & Harkness LLP ("C&H") for the purpose of briefing the Audit Committee of the Board of Directors of Belmont Ridge Bank National Association ("BRB" or the "Bank") in advance of the emergency session called for March 15, 2024. The emergency session has been convened in response to the SEC Staff's Wells call on March 8, 2024, in which Branch Chief Rena

II. Background and Procedural History A. Origin of the Investigation The SEC Division of Enforcement's interest in BRB's financial reporting for the BridgeFin consumer lending portfolio first became known to the Bank on September 18, 2023, when BRB's securities reporting counsel, Caldwell Pratt & Stein LLP ("CPS") — specifically, Martin Caldwell, lead partner, 51 West 52nd Street, 24th Floor, New York, NY 10019 — rec

III. Risk Assessment Matrix A. Charges and Legal Standards An understanding of the specific provisions the Staff is considering, and the legal standards applicable to each, is essential to evaluating BRB's risk exposure and formulating an appropriate response strategy.

Section 13(a) of the Exchange Act / Rule 13a-1. Section 13(a) requires issuers with securities registered under Section 12 of the Exchange Act to file periodic reports — including annual reports on Form 10-K and quarterly reports on Form 10-Q — with the Commission, and to include therein such information as the Commission prescribes. Rule 13a-1 implements this requirement with respect to annual reports. A violation o

Section 13(b)(2)(A) of the Exchange Act. Section 13(b)(2)(A) — commonly referred to as the "books and records" provision — requires every issuer to "make and keep books, records, and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the issuer." Like Section 13(a), this provision does not require scienter. The "reasonable detail" and "accurately an

1. No Scienter Allegation. The Staff has not indicated it is pursuing fraud charges. The absence of a scienter-based theory substantially narrows BRB's exposure and reflects the Staff's assessment — consistent with C&H's own review — that there is no evidence of intentional or reckless misconduct.

2. Reasonableness of CECL Methodology. BRB's ACL estimation for the BridgeFin portfolio was developed using a vintage-cohort approach that is widely accepted under ASC 326. The CECL framework explicitly contemplates the use of professional judgment and estimation, and there is no single "correct" ACL for any given portfolio. BRB's estimate of $143.5 million (3.50%) was within the range of reasonable estimates, and th

3. OCC Concurrence. The OCC, BRB's primary federal banking regulator, conducted a concurrent supervisory assessment of BRB's ACL methodology and did not identify a material deficiency. BRB maintains a satisfactory composite CAMELS rating of 2 under OCC Charter No. 24891. The absence of an adverse supervisory finding is a powerful indicator that BRB's approach was reasonable and consistent with regulatory expectations

4. Proactive Disclosure Enhancement. BRB voluntarily enhanced its BridgeFin disclosures in its Q3 2023 Form 10-Q (filed November 9, 2023). The enhanced disclosures included vintage-level delinquency tables and expanded Management's Discussion and Analysis ("MD&A") discussion of BridgeFin credit quality. These enhancements were undertaken at BRB's initiative, before the Staff raised any specific concerns about the ade

5. Favorable Witness Testimony. As detailed in Section II.D above, the three BRB witnesses who testified in the investigation — Ms. Navarrete, Mr. Chakravarti, and Mr. Hu — performed well under questioning. Their testimony was consistent, credible, and free of material adverse admissions. The testimony supports the defense narrative that BRB's ACL estimation was the product of a rigorous, good-faith process.

6. Improving Credit Metrics. Q4 2023 credit metrics for the BridgeFin portfolio show improving trends. The 90-plus-day delinquency rate is declining, and net charge-off rates have moderated. This trajectory validates BRB's original provisioning approach and undercuts the Staff's theory that the ACL was inadequate.

7. Expert Support. Brindoval Analytic Partners (Dr. Franklin Osei, CPA, CFF) has been retained and is preparing an expert report demonstrating the reasonableness of BRB's ACL methodology. Dr. Osei's analysis supports the conclusion that BRB's $143.5 million ACL was within the range of acceptable estimates under ASC 326.

8. Unqualified Audit Opinions. Whitfield Keane LLP (PCAOB Registration No. 2847), BRB's independent auditor, issued unqualified audit opinions on BRB's FY 2021 and FY 2022 financial statements. The auditor did not identify an error in BRB's ACL estimation and has not required or recommended a restatement. The fact that a major independent accounting firm — applying PCAOB auditing standards — concluded that BRB's fina

9. Full Cooperation. BRB cooperated fully with the investigation throughout its duration, producing nearly 1.42 million pages of documents, making three senior officers available for testimony, and responding promptly to all Staff requests. The Staff's acknowledgment of BRB's cooperation may be relevant to the exercise of its discretion. Factors Against BRB The following factors present risk for BRB and will likely b

1. Exceedance of Internal Materiality Threshold. The $37.3 million alleged understatement exceeds BRB's own internal materiality threshold of $30.6 million (5% of pre-tax income of $612 million) by $6.7 million. While the exceedance is relatively modest in absolute terms, the fact that BRB's own internal standard is exceeded provides the Staff with a quantitative anchor for its materiality argument.

2. Identifiable Methodological Practice. The re-aging of 12,847 loans ($236.4 million in outstanding balances) is an identifiable, discrete practice that the Staff can characterize as a specific methodological flaw rather than a mere difference of judgment. The Staff is likely to argue that BRB's policy of resetting delinquency clocks upon modification systematically obscured the true credit risk of the BridgeFin por

3. Quantitatively Significant Discrepancies. The discrepancies between BRB's reported metrics and the Staff's recalculated metrics are quantitatively significant. BRB reported a net charge-off rate of 2.14%, whereas the Staff's analysis yields a rate of 3.05%. Similarly, BRB reported a 90-plus-day delinquency rate of 1.72%, compared to the Staff's recalculated rate of 2.38% (which includes re-aged loans in their orig

4. Limited Loss History. BridgeFin is a relatively new lending platform, having launched in Q3 2020 with approximately three and a half years of operating history as of the relevant reporting dates. The limited loss history makes CECL estimation inherently less reliable and increases the importance of qualitative overlays — which the Staff may argue BRB should have applied more aggressively.

5. Collateral Consequences. Even a non-fraud enforcement action carries reputational cost and may trigger collateral proceedings. Securities class-action litigation is a common follow-on to SEC enforcement actions involving financial-reporting allegations. Shareholder derivative suits asserting breach of fiduciary duty by directors and officers are also possible. Additionally, the OCC could initiate its own superviso

IV. Litigation-Cost Projections A. Scenario-Based Cost Estimates C&H has prepared cost projections for each of the four principal scenarios identified in the Risk Assessment Matrix. These projections include external legal fees (C&H), expert fees (Brindoval Analytic Partners and potential additional experts), potential civil penalties, and undertaking compliance costs. They do not include BRB's internal costs (manage

V. Settlement Versus Contest Analysis The question of whether to pursue a settlement or contest any charges the Commission may bring is premature at this stage — the first priority is the Wells Submission, which is aimed at persuading the Staff not to recommend any action at all. However, the Audit Committee should be prepared for the possibility that the Wells Submission does not result in termination, and should un

1. File a robust Wells Submission aimed at persuading the Staff to recommend no enforcement action (i.e., termination of the investigation). The Wells Submission should present the strongest possible case for BRB, drawing on the five-pillar defense framework set forth in Section VII below.

2. Simultaneously prepare for settlement negotiations as a fallback. While the Wells Submission is pending, C&H should develop a settlement-negotiation framework, including acceptable terms (range of penalties, scope of undertakings, language of findings) and walk-away points.

3. Do NOT affirmatively approach the Staff to initiate settlement discussions before filing the Wells Submission. Pre-submission settlement overtures could signal a lack of confidence in BRB's position and undermine the Wells Submission's persuasive force. The submission should speak for itself.

4. If the Staff responds unfavorably after the Wells Submission — i.e., indicates that it still intends to recommend an enforcement action — then C&H should engage in pre-filing discussions with openness to a consent resolution on favorable terms. Acceptable terms would include: no admission of fraud or intentional wrongdoing; a civil penalty at the lower end of the Tier I range (ideally $500,000–$750,000); limited,

5. Reserve the right to contest if the proposed settlement terms are disproportionate to the conduct at issue. BRB should not agree to a settlement that includes onerous undertakings, excessive penalties, or findings language that could be characterized as an admission of material wrongdoing.

VI. D&O Insurance Coverage Analysis A. Policy Summary BRB maintains the following directors and officers liability insurance coverage: Primary Layer: Insurer: Northcastle Mutual Assurance Company Policy Number: NMA-DO-2023-11847 Policy Period: July 1, 2023 – July 1, 2024 Aggregate Limit: $15,000,000 Entity Retention (Self-Insured Retention/SIR): $2,500,000 Coverage: The policy covers defense costs, judgments, and set

VII. Recommended Wells Submission Strategy A. Overarching Theme The Wells Submission should advance a single, coherent overarching theme: BRB's ACL estimation for the BridgeFin portfolio was a reasonable, good-faith accounting judgment within the range of acceptable estimates permitted by the CECL framework (ASC 326). The differences between BRB's estimate and the Staff's retroactive analysis do not constitute a miss